AtriCure, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
AtriCure, Inc. (ATRC) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $0 as of 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-07-27
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-27 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-30 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-30 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-31 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 |
| 2023-09-30 | $3.33M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.33M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $3.33M 10-Q · filed 2023-05-03 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-03 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.67M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.67M 10-Q · filed 2021-04-28 |
| 2019-03-31 | $3.81M 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |